Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the effectiveness of brain training in a Virtual Reality set up in neurotypical populations as well as in the traumatic brain injury population.
Research Team
DT
Duje Tadin, PhD
Principal Investigator
University of Rochester
Eligibility Criteria
This trial is for adults over 18 with good hearing and vision, who don't play action or VR video games. It includes healthy young adults, older adults without neurological issues, and college athletes recently diagnosed with mild traumatic brain injury (concussion).Inclusion Criteria
Assigned to one of four groups: Control Group training in VR, Control Group training on a 2D display, Older Adult Group without dementia training in VR, College Athletes with mild TBI Group training in VR
I am over 18, can make my own decisions, and have normal or corrected vision and hearing.
Non-action video game player and non-VR game player
See 3 more
Exclusion Criteria
I am younger than 18 years old.
Treatment Details
Interventions
- Computer Screen Training (Behavioral Intervention)
- Virtual Reality Training (Behavioral Intervention)
Trial OverviewThe study compares the effectiveness of brain training exercises when done in Virtual Reality versus on a computer screen. It aims to see if VR can enhance cognitive rehabilitation after a traumatic brain injury.
Participant Groups
4Treatment groups
Experimental Treatment
Group I: Older Adult GroupExperimental Treatment1 Intervention
Older Adults over the age of 65 who will be training in Virtual Reality
Group II: Control in VRExperimental Treatment1 Intervention
Adults ages 18 to 35 who will be training in Virtual Reality.
Group III: Control Non-VRExperimental Treatment1 Intervention
Adults ages 18 to 35 who will be training on a computer screen.
Group IV: College Athletes with TBI GroupExperimental Treatment1 Intervention
Adults ages 18 to 35 with mild TBI who will be training in Virtual Reality
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
Trials
883
Recruited
555,000+
Kevin Koch
University of Rochester
Chief Executive Officer since 2020
PhD in Organic Chemistry from the University of Rochester
Brian Druker
University of Rochester
Chief Medical Officer since 2015
MD from Harvard Medical School
NeuroTrainer
Industry Sponsor
Trials
2
Recruited
240+
Neurotrainer
Collaborator
Trials
1
Recruited
80+
Related Searches
By Location